期刊文献+

肝病患者出凝血四项和D-D的检测分析 被引量:17

Detection and analysis of PT,APTT,FIB,TT and D-D in patients with liver disease
下载PDF
导出
摘要 目的研究凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、血浆纤维蛋白原(FIB)、血浆凝血酶时间(TT)及D-二聚体(D-D)对各型肝脏疾病的诊断价值。方法检测30例健康体检者和87例临床已确诊为肝病患者的PT、APTT、FIB、TT和D-D。前四项采用自动血凝仪检测,后一项采用乳胶凝集法检测。结果不同的肝病患者PT、APTT、FIB、TT和D-D与健康组对比,具有不同程度的差异。肝硬化、肝癌患者PT、APTT、TT时间延长(P<0.01),FIB含量降低(P<0.01),D-D水平较高,分别为72.2%和60.0%。急性肝炎组PT时间延长(P<0.01)、APTT时间也延长(P<0.01)、TT和FIB差异无统计学意义(P>0.05)、D-D平为18.8%,慢性肝炎组PT、APTT、TT时间延长(P<0.01),FIB含量无统计学意义(P>0.05),D-D水平为7.4%。各型肝脏疾病PT、APTT、TT的值和D-D水平呈现肝硬化组>肝癌组>慢性肝炎组>急性肝炎组,而FIB则相反。结论 PT、APTT、FIB、TT和D-D可客观地评价肝病患者的凝血功能状况,并且与肝病的严重程度相一致。这可以为临床肝脏疾病的诊断、治疗、动态观察以及判断预后提供重要依据,具有重要的临床价值。 Objective To study the diagnostic value of PT,APTT,FIB,TT and D-D on the various types of liver disease.Methods TTest the value of PT,APTT,FIB,TT and DD on 30 healthy volunteers and 87 patients who had been diagnosed to liver disease.The front four items were tested by automated coagulation analyzer and the last one was tested by latex agglutination assay.Results Compared with the healthy group,the values of PT,APTT,FIB,TT and D-D of different kinds of patients with liver disease had different degrees of difference.The values of PT,APTT,TT in cirrhosis group and liver cancer group prolonged(P0.01),FIB decreased(P0.01),the level of D-D was higher,72.2% and 60.0% respectively.In acute hepatitis group,PT prolonged(P0.01);APTT also prolonged(P0.05);TT and FIB had no significant difference;the level of D-D was 18.8%.In the chronic hepatitis group,PT,APTT,TT prolonged(P0.01);FIB had no difference;the level of D-D was 7.4%.The value of PT,APTT,FIB,TT and the level of D-D of various types of liver disease present cirrhosis group liver cancer group chronic hepatitis group acute hepatitis group,while the FIB is opposite.Conclusion PT,APTT,FIB,TT and D-D can objectively evaluate the coagulation status of patients with liver disease,which is consistent with severity of liver disease.They can provide important evidences for the diagnosis,treatment,dynamic observation and prognosis of clinical liver disease.
出处 《海南医学》 CAS 2011年第8期117-119,共3页 Hainan Medical Journal
  • 相关文献

参考文献9

二级参考文献50

  • 1黄尉国,王鸿利,张颖琪,朱立红,李耀辉,王学锋,程寅琳,邵慧珍,张鲁,葛维成.血浆D-二聚体检测及其临床应用[J].中华医学检验杂志,1995,18(2):71-74. 被引量:318
  • 2胡莹,项国雄.传者素养:媒介素养教育的根本[J].传媒观察,2005(8):42-43. 被引量:43
  • 3陈力丹.关于媒介素养与新闻教育的网上对话[J].湖南大众传媒职业技术学院学报,2007,7(2):12-17. 被引量:33
  • 4王鸿利.血栓和血液检验[M].北京:北京科学出版社,1999.1321.
  • 5沈根荣 余书文.重症肝炎[M].天津:天津科学技术出版社,1998.53.
  • 6江忠仪 巫向前 王鸿利.乙型肝炎病毒纤溶活性标志物水平测定及其临床意义[J].实用医学检验杂志,1999,6(1):29-29.
  • 7[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
  • 8[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
  • 9[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
  • 10[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.

共引文献1459

同被引文献151

引证文献17

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部